BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schranz D, Voelkel NF. "Nihilism" of chronic heart failure therapy in children and why effective therapy is withheld. Eur J Pediatr 2016;175:445-55. [PMID: 26895877 DOI: 10.1007/s00431-016-2700-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Luna F, Luyckx VA. Why have Non-communicable Diseases been Left Behind? Asian Bioeth Rev 2020;12:5-25. [PMID: 33717328 DOI: 10.1007/s41649-020-00112-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
2 Buchhorn R. Beta-blocker therapy in pediatric heart failure: 50 years lost to improve pharmacotherapy of a deadly disease. Ann Pediatr Cardiol 2021;14:341-2. [PMID: 34667405 DOI: 10.4103/apc.apc_126_21] [Reference Citation Analysis]
3 Schranz D, Krasemann T. A word on netting of angiotensin-converting enzyme inhibitor therapy in hypoplastic left heart syndrome following stage-I. Cardiol Young 2021;:1-4. [PMID: 34318741 DOI: 10.1017/S1047951121002936] [Reference Citation Analysis]
4 Schranz D, Akintuerk H, Voelkel NF. 'End-stage' heart failure therapy: potential lessons from congenital heart disease: from pulmonary artery banding and interatrial communication to parallel circulation. Heart 2017;103:262-7. [PMID: 28011759 DOI: 10.1136/heartjnl-2015-309110] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
5 Haller C, Friedberg MK, Laflamme MA. The role of regenerative therapy in the treatment of right ventricular failure: a literature review. Stem Cell Res Ther 2020;11:502. [PMID: 33239066 DOI: 10.1186/s13287-020-02022-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Ponzoni M, Frigo AC, Castaldi B, Cerutti A, Di Salvo G, Vida VL, Padalino MA. Surgical strategies for the management of end-stage heart failure in infants and children: A 15-year experience with a patient-tailored approach. Artif Organs 2021;45:1543-53. [PMID: 34461675 DOI: 10.1111/aor.14057] [Reference Citation Analysis]
7 Gasparini M, Cox N. Role of cardiac magnetic resonance strain analysis in patients with hypoplastic left heart syndrome in evaluating right ventricular (dys)function: a systematic review. Eur J Cardiothorac Surg 2021:ezab105. [PMID: 34331061 DOI: 10.1093/ejcts/ezab105] [Reference Citation Analysis]
8 de Waal K, Prasad R, Kluckow M. Patent ductus arteriosus management and the drift towards therapeutic nihilism - What is the evidence? Semin Fetal Neonatal Med 2021;26:101219. [PMID: 33653600 DOI: 10.1016/j.siny.2021.101219] [Reference Citation Analysis]
9 Reich B, Heye K, Tuura R, Beck I, Wetterling K, Hahn A, Hofmann K, Schranz D, Akintürk H, Latal B, Knirsch W. Neurodevelopmental Outcome and Health-related Quality of Life in Children With Single-ventricle Heart Disease Before Fontan Procedure. Semin Thorac Cardiovasc Surg 2017:S1043-0679(17)30288-5. [PMID: 29104017 DOI: 10.1053/j.semtcvs.2017.09.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
10 Schranz D, Recla S, Malcic I, Kerst G, Mini N, Akintuerk H. Pulmonary artery banding in dilative cardiomyopathy of young children: review and protocol based on the current knowledge. Transl Pediatr 2019;8:151-60. [PMID: 31161082 DOI: 10.21037/tp.2019.04.09] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
11 Ohye RG, Schranz D, D'Udekem Y. Current Therapy for Hypoplastic Left Heart Syndrome and Related Single Ventricle Lesions. Circulation 2016;134:1265-79. [PMID: 27777296 DOI: 10.1161/CIRCULATIONAHA.116.022816] [Cited by in Crossref: 73] [Cited by in F6Publishing: 26] [Article Influence: 14.6] [Reference Citation Analysis]
12 Schrewe R, Esmaeili A, Behnke-Hall K, Schranz D. Fulminant cytomegalovirus myocarditis in an infant with concomitant large atrial and ventricular septal defects: medical intervention strategy for functional cardiac regeneration. Cardiol Young 2019;29:277-9. [PMID: 30572976 DOI: 10.1017/S1047951118002160] [Reference Citation Analysis]
13 Alphonso N, Angelini A, Barron DJ, Bellsham-revell H, Blom NA, Brown K, Davis D, Duncan D, Fedrigo M, Galletti L, Hehir D, Herberg U, Jacobs JP, Januszewska K, Karl TR, Malec E, Maruszewski B, Montgomerie J, Pizzaro C, Schranz D, Shillingford AJ, Simpson JM; (Chaiman HLHS Guidelines Task Force). Guidelines for the management of neonates and infants with hypoplastic left heart syndrome: The European Association for Cardio-Thoracic Surgery (EACTS) and the Association for European Paediatric and Congenital Cardiology (AEPC) Hypoplastic Left Heart Syndrome Guidelines Task Force. European Journal of Cardio-Thoracic Surgery 2020;58:416-99. [DOI: 10.1093/ejcts/ezaa188] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
14 Schranz D, Akintuerk H, Esmaeili A, Latus H, Apitz C. Heart failure therapy based on interventricular mechanics and cardio-vascular communications. Cardiovasc Diagn Ther 2021;11:1080-8. [PMID: 34527534 DOI: 10.21037/cdt-20-347] [Reference Citation Analysis]
15 Recla S, Schmidt D, Logeswaran T, Esmaeili A, Schranz D. Pediatric heart failure therapy: why β1-receptor blocker, tissue ACE-I and mineralocorticoid-receptor-blocker? Transl Pediatr 2019;8:127-32. [PMID: 31161079 DOI: 10.21037/tp.2019.04.08] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
16 Di Candia A, Castaldi B, Bordin G, Cerutti A, Reffo E, Biffanti R, Di Salvo G, Vida VL, Padalino MA. Pulmonary Artery Banding for Ventricular Rehabilitation in Infants With Dilated Cardiomyopathy: Early Results in a Single-Center Experience. Front Pediatr 2020;8:347. [PMID: 32766180 DOI: 10.3389/fped.2020.00347] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Poulsen CB, Damkjær M. Trends in prescription of cardiovascular drugs to children in relation to prevalence of CHD from 1999 to 2016. Cardiol Young 2018;28:1136-41. [PMID: 29991362 DOI: 10.1017/S1047951118000951] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]